Determining the right avenue of treatment for herpes zoster ophthalmicus (HZO), which occurs when the varicella-zoster virus (VZV) is reactivated in the ophthalmic section of the trigeminal nerve, can be a challenge. While antiviral use during the acute, infectious stage is common, treatment in later, post-infectious stages can vary. With the potential for chronic and recurrent disease, it can be difficult for clinicians to identify the right management approach.
By Aaron Bronner, OD
Review of Optometry CE, May 2021
Optometric Study Center: Courses published monthly in Review of Optometry and Review of Cornea & Contact Lenses, offering either 1 or 2 hours of CE credit. Processing fees apply. Exam valid for credit up to three years from release date.
Supported CE: Courses offered without exam fee, supported by an independent educational grant from a commercial interest. Typically valid for credit for one year from release date; longer active terms may exist for some exams.
Archived CE: Courses have expired but are displayed for reader interest. No credits available.